Pharmaceutical Position Paper 2013/2014

Pharmaceutical Position Paper 2013/2014 - 制药建议书 2013/2014 Go back »

Published on:

2013-09-05
Category:

Position Paper
by:

Pharmaceutical Working Group / Forum
Keywords:

pharmaceutical, position paper

Download

The Pharmaceutical Working Group represents 31 foreign pharmaceutical manufacturing companies operating in China.

The Pharmaceutical Working Group encourages government policies that support the creation of a sustainable system that fosters innovation and healthy growth of the pharmaceutical industry as a whole, while improving patient access to innovative high qualitymedicines, in line with China’s declared strategic objectives for the healthcare sector. Policies related to pricing, reimbursement and intellectual property are the most potentially useful tools for rewarding quality and safety while creating incentives for domestic and multinational companies alike to bring innovative medicines to the Chinese market.

The Working Group supports establishment of a transparent government policy mechanism to solicit comments and participation from the pharmaceutical industry (both local and foreign) before formal policy announcements involving pricing, reimbursement, intellectual property rights (IPR) etc.

The European Union (EU) pharmaceutical industry is a major contributor to both the EU and Chinese economies and to the world pharmaceutical market.

All Working Groups